February 10, 2021 – BD (Becton, Dickinson and Company) (Franklin Lakes, NJ) announced the appointment of Dev Kurdikar to the position of worldwide president, BD Diabetes Care, effective Feb. 10.
In his new role, Kurdikar will have responsibility for driving global strategic, operational and commercial performance across a portfolio of solutions that aims to minimize the burdens and complications for people with diabetes.
Most recently, Kurdikar served as CEO and president for Cardiac Science, a global manufacturer of automated external defibrillators (AEDs). Previously, he was the general manager for the men’s health business within American Medical Systems (AMS) and held positions of increasing responsibility and leadership with Baxter, including vice president of the Infusion Systems business in the U.S. and vice president of Marketing/Strategy for enterprise-wide commercial initiatives.